Harrow, Inc. Preferred Stock Dividends and Other Adjustments
Harrow, Inc. (HROW) reported Preferred Stock Dividends and Other Adjustments of $472.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2023-03-23
- Harrow, Inc. preferred stock dividends and other adjustments for the quarter ending 2021-12-31 was $0.00.
- Harrow, Inc. preferred stock dividends and other adjustments for the quarter ending 2021-09-30 was $0.00.
- Harrow, Inc. preferred stock dividends and other adjustments for the quarter ending 2021-06-30 was $472.00K.
- Harrow, Inc. preferred stock dividends and other adjustments for the quarter ending 2013-03-31 was $0.00.
- Harrow, Inc. preferred stock dividends and other adjustments for fiscal 2021 was $472.00K.
- Harrow, Inc. preferred stock dividends and other adjustments for fiscal 2012 was $200.00K, a 100.00% increase from fiscal 2011.
- Harrow, Inc. preferred stock dividends and other adjustments for fiscal 2011 was $100.00K.
- Harrow, Inc. preferred stock dividends and other adjustments for fiscal 2010 was $0.00.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month | Preferred Stock Dividends and Other Adjustments 161 month | Preferred Stock Dividends and Other Adjustments 164 month | Preferred Stock Dividends and Other Adjustments 167 month | Preferred Stock Dividends and Other Adjustments 170 month | Preferred Stock Dividends and Other Adjustments 173 month | Preferred Stock Dividends and Other Adjustments 176 month | Preferred Stock Dividends and Other Adjustments 182 month | Preferred Stock Dividends and Other Adjustments 185 month | Preferred Stock Dividends and Other Adjustments 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $472.00K derived: sum of 3 quarters · filed 2023-03-23 | $472.00K 10-K · filed 2023-03-23 | |||||||||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $472.00K derived: sum of 2 quarters · filed 2022-11-14 | $472.00K 10-Q · filed 2022-11-14 | ||||||||||
| 2021-06-30 | $472.00K 10-Q · filed 2022-08-09 | $472.00K 10-Q · filed 2022-08-09 | |||||||||||
| 2014-03-31 | $300.00K 10-Q · filed 2014-05-15 | ||||||||||||
| 2013-12-31 | $300.00K 10-K · filed 2014-03-28 | ||||||||||||
| 2013-09-30 | $300.00K 10-Q · filed 2013-11-06 | ||||||||||||
| 2013-06-30 | $300.00K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-03-28 | $200.00K derived: sum of 4 quarters · filed 2014-03-28 | $300.00K 10-Q · filed 2013-05-08 | ||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $200.00K derived: sum of 3 quarters · filed 2014-03-28 | $200.00K 10-K · filed 2014-03-28 | $300.00K 10-K · filed 2013-03-18 | ||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $200.00K derived: sum of 2 quarters · filed 2013-11-06 | $200.00K 10-Q · filed 2013-11-06 | $300.00K 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | $200.00K 10-Q · filed 2013-08-14 | $200.00K 10-Q · filed 2013-08-14 | $300.00K 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 | $100.00K 10-Q · filed 2012-05-10 | |||||||||||
| 2011-12-31 | $100.00K 10-K · filed 2013-03-18 | $100.00K 10-K · filed 2012-02-23 | |||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | ||||||||||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |